Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.amjcard.2020.12.086 http://scihub22266oqcxt.onion/10.1016/j.amjcard.2020.12.086 33454341!7836376!33454341     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Cardiol 2021 ; 145 (ä): 97-101 Nephropedia Template TP {{tp|p=33454341|t=2021. Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic |pdf=|usr=}}{{33454341}} gab.com Text Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic JO: Am J Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=33454341 #FOAvip Transcatheter aortic valve implantation (TAVI) outcomes during the coronavirus disease 2019 (COVID-19) pandemic have not been fully evaluated and some structural programs in the world have been suspended during this period. We sought to evaluate and compare clinical outcomes in patients undergoing TAVI in pandemic versus nonpandemic era. In a single center, we compared 198 TAVI patients performed during 2019 to 59 patients performed during the COVID-19 pandemic period (March 1st to June 30th, 2020). Primary outcome was procedural success according to VARC criteria and 30-day mortality rates. VARC-defined procedural success was high in both groups (93.3% vs 96.6%; p?=?0.53). There were no differences in any vascular complications (26% vs 19%; p?=?0.3), permanent pacemaker implantation (11.8% vs 15.3%; p = 0.63), and length of hospital stay (5.2 vs 4.2 days; p?=?0.29). Thirty-day mortality was similar (3% vs 3.4%; p?=?1.0). We had no documented COVID-19 disease in our patients during follow up. In conclusion, TAVI procedures can be performed effectively and safely during the COVID-9 pandemic, using a minimalist approach, early discharge, and by maintaining proper use of personal protective equipment. Twit Text FOAVip Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic ????Am J Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=33454341 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33454341 #FOAvip English Wikipedia <ref>{{Cite pmid|33454341}}</ref> Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic #MMPMID33454341 Valdebenito M; Massalha E; Barbash IM; Maor E; Fefer P; Guetta V; Segev A Am J Cardiol 2021[Apr]; 145 (ä): 97-101 PMID33454341show ga Transcatheter aortic valve implantation (TAVI) outcomes during the coronavirus disease 2019 (COVID-19) pandemic have not been fully evaluated and some structural programs in the world have been suspended during this period. We sought to evaluate and compare clinical outcomes in patients undergoing TAVI in pandemic versus nonpandemic era. In a single center, we compared 198 TAVI patients performed during 2019 to 59 patients performed during the COVID-19 pandemic period (March 1st to June 30th, 2020). Primary outcome was procedural success according to VARC criteria and 30-day mortality rates. VARC-defined procedural success was high in both groups (93.3% vs 96.6%; p?=?0.53). There were no differences in any vascular complications (26% vs 19%; p?=?0.3), permanent pacemaker implantation (11.8% vs 15.3%; p = 0.63), and length of hospital stay (5.2 vs 4.2 days; p?=?0.29). Thirty-day mortality was similar (3% vs 3.4%; p?=?1.0). We had no documented COVID-19 disease in our patients during follow up. In conclusion, TAVI procedures can be performed effectively and safely during the COVID-9 pandemic, using a minimalist approach, early discharge, and by maintaining proper use of personal protective equipment. |*Pandemics[MESH] |*Registries[MESH] |Aged, 80 and over[MESH] |Aortic Valve/*surgery[MESH] |COVID-19/*epidemiology[MESH] |Comorbidity[MESH] |Female[MESH] |Heart Valve Diseases/epidemiology/*surgery[MESH] |Humans[MESH] |Male[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH] |Transcatheter Aortic Valve Replacement/*methods[MESH]Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing